CLINICAL_TRIALS
trial_result
· 2017-03-30
Clinical Trial Update: A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder [Phase 2]
Summary
Phase 2 randomized, placebo-controlled trial evaluating stellate ganglion block for post-traumatic stress disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: United States Naval Medical Center, San Diego | Conditions: Post Traumatic Stress Disorder (PTSD) | Phase 2 | Status: COMPLETED